The identification of rearrangements in CIC gene in CDS has paved the way for a better understanding of the role of CIC in more common cancers and questioned whether patients with CIC-rearranged sarcomas should be included in basket trials with patients who have different types of cancer, rather than with patients diagnosed with EWS or soft-tissue sarcomas. The gene discussed is EWSR1; the disease is cancer.